"Challenges for Parents Seeking Generics for Kids with Asthma as Flovent Inhaler Goes Off Market"
After the discontinuation of Flovent inhaler, some parents are facing challenges in obtaining generic versions for their children with asthma. The transition from branded to authorized generics is expected to have minimal disruption for patients, but some insurance plans may cause delays if they don't cover the generic. The switch to generic versions may impact effectiveness on individual patients, as different types of inhalers require different usage techniques. GSK, the pharmaceutical company that made Flovent, has discontinued manufacturing the inhaler in the U.S. as of Jan. 1, 2024.